Eaton Vance Management Accelerate Diagnostics, Inc Transaction History

Eaton Vance Management

  • $67.5 Billion
  • Q3 2022

A detailed history of Eaton Vance Management transactions in Accelerate Diagnostics, Inc stock. As of the latest transaction made, Eaton Vance Management holds 223,215 shares of AXDX stock, worth $245,536. This represents 0.0% of its overall portfolio holdings.

Number of Shares
223,215
Previous 223,215 -0.0%
Holding current value
$245,536
Previous $222,000 52.7%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2017

Nov 13, 2017
BUY
$21.1 - $25.15 $4.71 Million - $5.61 Million
223,215
223,215 $5.01 Million

Others Institutions Holding AXDX

# of Institutions
3
Shares Held
549K
Call Options Held
0
Put Options Held
0
View Full List

About Accelerate Diagnostics, Inc

AXDX Quotes by TradingView
  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $109M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Eaton Vance Management Portfolio

Follow Eaton Vance Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email